COMPOUND OVERVIEW

Tesamorelin is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH), a 44-amino acid peptide that stimulates the pituitary gland to produce and release growth hormone (GH). It was developed to mimic the endogenous GHRH molecule while offering enhanced stability and potency. Tesamorelin has been extensively studied for its role in reducing visceral adipose tissue and its downstream metabolic effects, making it one of the most well-characterized peptides in the GH axis research space.

MECHANISM OF ACTION

Tesamorelin binds to GHRH receptors on anterior pituitary somatotroph cells, triggering intracellular cAMP signaling cascades that stimulate the synthesis and pulsatile secretion of endogenous growth hormone. Unlike exogenous GH administration, Tesamorelin works within the body’s natural feedback loop — preserving the physiological regulation of IGF-1 and avoiding sustained supraphysiological GH spikes. Research shows it selectively reduces visceral fat without significantly altering subcutaneous fat, insulin sensitivity, or glucose metabolism, distinguishing it from direct GH administration in metabolic research.

RESEARCH APPLICATIONS

• Visceral adiposity and metabolic syndrome research
• Growth hormone deficiency and GH axis modulation studies
• Body composition research in metabolic and endocrine models
• Lipodystrophy and adipose tissue redistribution studies
• Cognitive function and neurological GH axis research
• Cardiovascular risk factor modulation in preclinical models

KEY RESEARCH FINDINGS

• Studies in research models demonstrated significant reductions in visceral adipose tissue (VAT) with sustained Tesamorelin administration over 26 weeks
• Research indicates Tesamorelin elevates IGF-1 levels in a dose-dependent manner, consistent with GH axis activation
• Cognitive studies in research models suggest GH axis stimulation via Tesamorelin may have neuroprotective applications
• Minimal effect on glucose homeostasis observed in short-term research protocols — a key differentiator from exogenous GH
• Research has explored its use in age-related GH decline and associated metabolic consequences

STORAGE & HANDLING

• Store lyophilized powder at -20°C; stable for up to 24 months when properly stored
• Once reconstituted with bacteriostatic water, store at 2–8°C and use within 28 days
• Protect from light and moisture at all times
• Do not freeze reconstituted solution
• Handle with sterile technique in a controlled research environment

SPECIFICATIONS

DISCLAIMER: This compound is sold strictly for laboratory and research purposes only. It is not intended for human consumption, clinical use, or veterinary application. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. For use by licensed researchers and qualified professionals only. You must be 21 years of age or older to purchase.

usaminopeptides.com · For Researcher Inquiries Contact: info@usaminopeptides.com